スピルリナ市場：タイプ別、製剤別、用途別-2025-2030年の世界予測

スピルリナ市場は、2023年に3億8,998万米ドルと評価され、2024年には4億1,991万米ドルに達すると予測され、CAGR 7.77％で成長し、2030年には6億5,849万米ドルに達すると予測されています。

スピルリナは、その栄養学的利点のために消費されるシアノバクテリウムであり、健康とウェルネスの分野で注目されており、その応用範囲全体にわたって十分な機会が約束されています。スピルリナは、豊富なタンパク質、ビタミン、抗酸化特性を持つことから、栄養補助食品、医薬品、飲食品、飼料、化粧品に使用され、その範囲は拡大しています。スピルリナの必要性は、世界の栄養不良や食生活の欠乏に対処することを目的とした、植物由来の持続可能な栄養源に対する消費者の志向の高まりから生じています。食品の強化、免疫機能サプリメントの強化、食品や化粧品の天然着色料としての役割など、その最終用途は多岐にわたる。

市場力学は、健康動向と菜食主義の高まりに大きく影響され、特に栄養補助食品と化粧品分野で有利な潜在機会をもたらしています。さらに、閉鎖系光バイオリアクターの使用など、培養プロセスの革新は、生産効率と品質向上の機会を提供します。しかし、生産コストの高さ、培養中の汚染リスク、新興国市場での認知度の低さといった課題が、市場の成長を妨げています。さらに、微細藻類と水生毒素を結びつける消費者の認識が障壁となっています。成長機会を生かすために、利害関係者は啓発キャンペーンに投資し、費用対効果の高い栽培技術を開発することが奨励されます。

イノベーションの機会は、スピルリナに基づく機能性食品や強化食品の創出、ペットや動物の栄養における利用の拡大、バイオ燃料生産の特性の探求にあります。さらに、スピルリナの消化性と嗜好性を向上させる調査により、その受容性が広がるであろう。市場は断片的な競争によって特徴付けられているが、持続可能で健康志向の消費者動向と合致しているため、計り知れない可能性を示しています。研究開発のために戦略的パートナーシップを結び、持続可能なサプライチェーンの確立に注力する企業が、ダイナミックに進化するこの分野のリーダーとして台頭してくると思われます。

市場力学：急速に進化するスピルリナ市場における主要市場インサイトの解明

スピルリナ市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • スピルリナスーパーフードの自然な健康効果に対する認識
  • がん治療におけるスピルリナの重要性
  • シアノバクテリアの減量とパーソナルケアに対する高い需要
• 市場抑制要因
  • スピルリナの高コスト
• 市場機会
  • スピルリナの増産に向けた政府の取り組み
  • スピルリナから生産される天然着色料の新品種のイントロダクション
• 市場の課題
  • スピルリナの過剰摂取による副作用のリスク

ポーターの5つの力：スピルリナ市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、スピルリナ市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：スピルリナ市場における外部からの影響の把握

外部マクロ環境要因は、スピルリナ市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析スピルリナ市場における競合情勢の把握

スピルリナ市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックススピルリナ市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、スピルリナ市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨スピルリナ市場における成功への道筋を描く

スピルリナ市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • スピルリナスーパーフードの自然な健康効果の認識
    • がん治療におけるスピルリナの重要性
    • 減量とパーソナルケアのためのシアノバクテリアの需要が高い
  • 抑制要因
    • スピルリナのコストが高い
  • 機会
    • スピルリナの生産増加に向けた政府の取り組み
    • スピルリナから生まれた天然食品着色料の新品種のイントロダクション
  • 課題
    • スピルリナの過剰摂取による副作用のリスク
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 スピルリナ市場：タイプ別

• アルスロスピラ・マキシマ
• アルスロスピラ・プラテンシス

第7章 スピルリナ市場薬剤処方別

• 顆粒剤およびゲル化剤
• 液体
• 粉
• タブレットとカプセル

第8章 スピルリナ市場：用途別

• 動物飼料
• 化粧品
• 食品・飲料
• 栄養補助食品

第9章 南北アメリカのスピルリナ市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のスピルリナ市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのスピルリナ市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Algenol Biofuels Inc.
• Australian Spirulina
• Cabassi & Giuriati SpA
• Chr. Hansen Holding A/S
• DDW The Color House
• DIC Corporation
• Dongtai City Spirulina Bio-engineering Co., Ltd
• DOHLER GmbH
• Earthrise Nutritionals, LLC
• Fuqing King Dnarmsa Spirulina Co. Ltd
• GNC Holdings, Inc.
• GNT Holding B.V.
• Inner Mongolia Rejuve Biotech Co. Ltd.
• Naturex S.A
• Now Health Group Inc.

LIST OF FIGURES

• FIGURE 1. SPIRULINA MARKET RESEARCH PROCESS
• FIGURE 2. SPIRULINA MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL SPIRULINA MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL SPIRULINA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL SPIRULINA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL SPIRULINA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL SPIRULINA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL SPIRULINA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL SPIRULINA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS SPIRULINA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS SPIRULINA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES SPIRULINA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES SPIRULINA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. SPIRULINA MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. SPIRULINA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. SPIRULINA MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL SPIRULINA MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SPIRULINA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL SPIRULINA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. SPIRULINA MARKET DYNAMICS
• TABLE 7. GLOBAL SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL SPIRULINA MARKET SIZE, BY ARTHROSPIRA MAXIMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL SPIRULINA MARKET SIZE, BY ARTHROSPIRA PLATENSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL SPIRULINA MARKET SIZE, BY GRANULE & GELLING AGENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL SPIRULINA MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL SPIRULINA MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL SPIRULINA MARKET SIZE, BY TABLET & CAPSULE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL SPIRULINA MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL SPIRULINA MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL SPIRULINA MARKET SIZE, BY FOOD & BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL SPIRULINA MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS SPIRULINA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. CANADA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 32. CANADA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES SPIRULINA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. CHINA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 49. CHINA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. INDIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 52. INDIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ITALY SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 104. ITALY SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. POLAND SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 116. POLAND SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. QATAR SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 119. QATAR SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. SPIRULINA MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 148. SPIRULINA MARKET, FPNV POSITIONING MATRIX, 2023

The Spirulina Market was valued at USD 389.98 million in 2023, expected to reach USD 419.91 million in 2024, and is projected to grow at a CAGR of 7.77%, to USD 658.49 million by 2030.

Spirulina, a cyanobacterium consumed for its nutritional benefits, has gained attention in the health and wellness sector, promising ample opportunities across its application spectrum. The scope of spirulina is expansive, defined by its use in dietary supplements, pharmaceuticals, food and beverages, animal feed, and cosmetics, owing to its rich protein content, vitamins, and antioxidant properties. The necessity of spirulina emerges from the increasing consumer inclination toward plant-based and sustainable nutritional sources, aiming to tackle malnutrition and dietary deficiencies globally. Its application in fortifying food products, bolstering immune function supplements, and acting as a natural colorant in food and cosmetics outlines a broad end-use scope.

Market dynamics are significantly influenced by health trends and growing veganism, which presents lucrative potential opportunities, particularly in the dietary supplement and cosmetics sectors. Moreover, innovations in cultivation processes, such as the use of closed-system photobioreactors, present opportunities for increased production efficiency and quality enhancement. However, challenges such as high production costs, contamination risk during cultivation, and limited awareness in developing regions hinder market growth. Additionally, consumer perception linking microalgae to aquatic toxins poses a barrier. To capitalize on growth opportunities, stakeholders are encouraged to invest in awareness campaigns and develop cost-effective cultivation technologies.

Innovation opportunities lie in creating spirulina-based functional and fortified food products, expanding its use in pet and animal nutrition, and exploring biofuel production attributes. Moreover, research into enhancing the digestibility and taste of spirulina would broaden its acceptability. The market is characterized by fragmented competition but shows immense potential owing to its alignment with sustainable and health-centric consumer trends. Companies engaging in strategic partnerships for research and development and focusing on establishing sustainable supply chains will likely emerge as leaders in this dynamically evolving sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Spirulina Market

The Spirulina Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Awareness of natural health benefits of spirulina superfood
  • Importance of Spirulina in cancer treatment
  • High demand for cyanobacteria for weight reduction and personal care
• Market Restraints
  • High cost of spirulina
• Market Opportunities
  • Government initiatives for increasing the production of spirulina
  • Introduction of new varieties of natural food colors produced from spirulina
• Market Challenges
  • Risk of side effects of overconsumption of spirulina

Porter's Five Forces: A Strategic Tool for Navigating the Spirulina Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Spirulina Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Spirulina Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Spirulina Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Spirulina Market

A detailed market share analysis in the Spirulina Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Spirulina Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Spirulina Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Spirulina Market

A strategic analysis of the Spirulina Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Spirulina Market, highlighting leading vendors and their innovative profiles. These include Algenol Biofuels Inc., Australian Spirulina, Cabassi & Giuriati SpA, Chr. Hansen Holding A/S, DDW The Color House, DIC Corporation, Dongtai City Spirulina Bio-engineering Co., Ltd, DOHLER GmbH, Earthrise Nutritionals, LLC, Fuqing King Dnarmsa Spirulina Co. Ltd, GNC Holdings, Inc., GNT Holding B.V., Inner Mongolia Rejuve Biotech Co. Ltd., Naturex S.A, and Now Health Group Inc..

Market Segmentation & Coverage

This research report categorizes the Spirulina Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Arthrospira Maxima and Arthrospira Platensis.
• Based on Drug Formulation, market is studied across Granule & Gelling Agent, Liquid, Powder, and Tablet & Capsule.
• Based on Application, market is studied across Animal Feed, Cosmetics, Food & Beverages, and Nutraceuticals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Awareness of natural health benefits of spirulina superfood
    • 5.1.1.2. Importance of Spirulina in cancer treatment
    • 5.1.1.3. High demand for cyanobacteria for weight reduction and personal care
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of spirulina
  • 5.1.3. Opportunities
    • 5.1.3.1. Government initiatives for increasing the production of spirulina
    • 5.1.3.2. Introduction of new varieties of natural food colors produced from spirulina
  • 5.1.4. Challenges
    • 5.1.4.1. Risk of side effects of overconsumption of spirulina
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Spirulina Market, by Type

• 6.1. Introduction
• 6.2. Arthrospira Maxima
• 6.3. Arthrospira Platensis

7. Spirulina Market, by Drug Formulation

• 7.1. Introduction
• 7.2. Granule & Gelling Agent
• 7.3. Liquid
• 7.4. Powder
• 7.5. Tablet & Capsule

8. Spirulina Market, by Application

• 8.1. Introduction
• 8.2. Animal Feed
• 8.3. Cosmetics
• 8.4. Food & Beverages
• 8.5. Nutraceuticals

9. Americas Spirulina Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Spirulina Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Spirulina Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Algenol Biofuels Inc.
• 2. Australian Spirulina
• 3. Cabassi & Giuriati SpA
• 4. Chr. Hansen Holding A/S
• 5. DDW The Color House
• 6. DIC Corporation
• 7. Dongtai City Spirulina Bio-engineering Co., Ltd
• 8. DOHLER GmbH
• 9. Earthrise Nutritionals, LLC
• 10. Fuqing King Dnarmsa Spirulina Co. Ltd
• 11. GNC Holdings, Inc.
• 12. GNT Holding B.V.
• 13. Inner Mongolia Rejuve Biotech Co. Ltd.
• 14. Naturex S.A
• 15. Now Health Group Inc.